Antiprothrombinase and Factor II Deficiency in a Non SLE Patient

• References

• 1 Conley CL, Hartman RC. A hemorragie disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621-622
• 2 Schieider MA, Nachman RL, Jaffee EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499-509
• 3 Lechner K. Acquired inhibitors in nonhemophiliac patients. Haemostasis 1974; 3: 065-093
• 4 Bonnin JA, Cohen AK, Hicks ND. Coagulation defects in a case of systemic lupus erythematosus with thrombocytopenia. Br J Haemat 1956; 2: 168-179
• 5 Clauvel JP, Sultan Y. Anticoagulant circulant et syndrome de Willebrand au cours du lupus erythémateux disséminé. Actualités Hématologiques Masson ed Paris: 1977. p 109
• 6 Corrigan JJ, Patherson JH, May NE. Incoagulability of the blood in systemic lupus erythematosus. Am J Dis Child 1970; 119: 365-369
• 7 Frick PG. Acquired circulating anticoagulant in systemic collagen disease. Blood 1955; 10: 691-706
• 8 Gonyea L, Herdman R, Brigdes RA. The coagulation abnormalities in systemic lupus erythematosus. Thrombos Diathes Haemorrh 1968; 20: 457-464
• 9 Loeliger A, Alsbach EJ J. Prothrombin as Co-factor of the circulating anticoagulant in systemic lupus erythematosus. Thrombos Diathes Haemorrh 1959; 3: 237-256
• 10 Ramot B, Singer K. An unusual circulating anticoagulant in systemic lupus erythematosus. Acta Haematol 1956; 16: 158-169
• 11 Rapaport SI, Ames SB, Duvall BJ. A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity. Blood 1960; 15: 212-227
• 12 Regan MG, Lackner H, Karpatkin S. Platelet function profile in lupus erythematosus. Ann Int Med 1974; 81: 462-468